Intellia Therapeutics, Inc. (NTLA)

Latest Insider Confidence Score

2026Q1

50.4
Bullish

Company insider confidence (by quarter)

2016Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Haurwitz Rachel E. — 5,244,234 May 11, 2016
Caribou Therapeutics Holdco, LLC — 5,244,234 May 11, 2016
Caribou Biosciences, Inc. 10% Owner 3,994,355 Jan 30, 2018
Atlas Venture Fund IX, L.P. 10% Owner 3,579,788 Jul 11, 2017
Atlas Venture Associates IX, L.P. 10% Owner 3,579,788 Jul 11, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 1, 2026 Mar 3, 2026 LEONARD JOHN M CEO Neutral 90.0 +156,400 14.59% ✗ -
Mar 1, 2026 Mar 3, 2026 BASTA JAMES EVP, General Counsel Sell 91.3 +44,869 40.09% ✗ $16.7K
Mar 1, 2026 Mar 3, 2026 Lebwohl David EVP, Chief Medical Officer Neutral 85.0 +9,943 8.20% ✗ -
Mar 1, 2026 Mar 3, 2026 Dulac Edward J III CFO Neutral 90.0 +61,280 61.47% ✗ -
Mar 1, 2026 Mar 3, 2026 Schultes Birgit C EVP, Chief Scientific Officer Neutral 90.0 +39,200 39.78% ✗ -
Mar 1, 2026 Mar 3, 2026 Clark Eliana EVP, Chief Technical Officer Sell 85.0 +6,746 7.74% ✗ $8.4K
Mar 1, 2026 Mar 3, 2026 Dube Michael P VP, Chief Accounting Officer Neutral 90.0 +17,250 33.00% ✗ -
Jan 5, 2026 Jan 7, 2026 LEONARD JOHN M CEO Sell 40.0 -34,146 -3.09% ✗ $314.5K
Jan 5, 2026 Jan 7, 2026 Schultes Birgit C EVP, Chief Scientific Officer Sell 42.5 -8,508 -7.95% ✗ $78.4K
Jan 5, 2026 Jan 7, 2026 BASTA JAMES EVP, General Counsel Sell 42.5 -10,397 -9.29% ✗ $95.8K
Jan 5, 2026 Jan 7, 2026 Cohen Fred E Director Buy 100.0 +150,000 261.08% ✗ $1.4M
Jan 5, 2026 Jan 7, 2026 Lebwohl David EVP, Chief Medical Officer Sell 42.5 -11,903 -8.94% ✗ $109.6K
Jan 5, 2026 Jan 7, 2026 Clark Eliana EVP, Chief Technical Officer Sell 42.5 -9,515 -9.85% ✗ $87.6K
Jan 5, 2026 Jan 7, 2026 Dulac Edward J III CFO Sell 42.5 -6,379 -6.01% ✗ $58.8K
Jan 5, 2026 Jan 7, 2026 Dube Michael P VP, Chief Accounting Officer Sell 46.3 -2,989 -5.41% ✗ $27.5K
Dec 11, 2025 Dec 12, 2025 LEONARD JOHN M CEO Sell 30.0 -88,146 -7.44% ✓ $836.4K
Oct 1, 2025 Oct 3, 2025 Schultes Birgit C EVP, Chief Scientific Officer Sell 52.5 -31 -0.03% ✗ $538.8
Oct 1, 2025 Oct 3, 2025 Dube Michael P VP, Chief Accounting Officer Sell 46.3 -1,871 -3.27% ✗ $32.5K
Aug 20, 2025 Aug 22, 2025 CHASE WILLIAM J Director Buy 100.0 +100,000 288.24% ✗ $1M
Jul 23, 2025 Jul 25, 2025 Dulac Edward J III CFO Sell 42.5 -7,462 -6.57% ✗ $104.6K
Jul 1, 2025 Jul 3, 2025 Clark Eliana EVP, Chief Technical Officer Sell 26.3 -1,022 -1.06% ✗ $10K
Jul 2, 2025 Jul 3, 2025 Dube Michael P VP, Chief Accounting Officer Sell 46.3 -2,503 -4.20% ✗ $24.9K
Jun 30, 2025 Jul 2, 2025 GOODMAN JESSE Director Sell 28.8 -3,094 -11.27% ✓ $29.1K
Jun 11, 2025 Jun 18, 2025 Keresty Georgia Director Neutral 90.0 +8,000 33.50% ✗ -
Jun 11, 2025 Jun 13, 2025 Verwiel Frank Director Neutral 90.0 +8,000 44.57% ✗ -
Jun 11, 2025 Jun 13, 2025 GOODMAN JESSE Director Neutral 90.0 +8,000 41.12% ✗ -
Jun 11, 2025 Jun 13, 2025 Goff Brian Director Neutral 90.0 +8,000 51.92% ✗ -
Jun 11, 2025 Jun 13, 2025 Bhanji Muna Director Neutral 90.0 +8,000 41.66% ✗ -
Jun 11, 2025 Jun 13, 2025 CHASE WILLIAM J Director Neutral 90.0 +8,000 29.97% ✗ -
Jun 11, 2025 Jun 13, 2025 Cohen Fred E Director Neutral 90.0 +8,000 16.18% ✗ -
Apr 29, 2025 May 1, 2025 Bhanji Muna Director Sell 50.0 -265 -1.36% ✓ $2.3K
Mar 1, 2025 Mar 4, 2025 Clark Eliana EVP, Chief Technical Officer Sell 90.0 +31,321 48.90% ✗ $6.1K
Mar 1, 2025 Mar 4, 2025 LEONARD JOHN M CEO Neutral 90.0 +136,000 13.61% ✗ -
Mar 1, 2025 Mar 4, 2025 Dulac Edward J III CFO Neutral 90.0 +47,200 71.17% ✗ -
Mar 1, 2025 Mar 4, 2025 Dube Michael P VP, Chief Accounting Officer Neutral 90.0 +14,000 30.67% ✗ -
Mar 1, 2025 Mar 4, 2025 Lebwohl David EVP, Chief Medical Officer Neutral 90.0 +43,200 49.28% ✗ -
Mar 1, 2025 Mar 4, 2025 Schultes Birgit C EVP, Chief Scientific Officer Neutral 90.0 +37,600 55.61% ✗ -
Mar 1, 2025 Mar 4, 2025 BASTA JAMES EVP, General Counsel Sell 91.3 +37,428 50.24% ✗ $23.1K
Jan 29, 2025 Jan 31, 2025 Bhanji Muna Director Sell 50.0 -265 -1.34% ✓ $2.6K
Jan 23, 2025 Schultes Birgit C EVP, Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2025 Jan 7, 2025 Dube Michael P VP, Chief Accounting Officer Sell 46.3 -1,372 -2.92% ✗ $16.7K
Jan 3, 2025 Jan 7, 2025 BASTA JAMES EVP, General Counsel Sell 42.5 -7,074 -8.67% ✗ $86.2K
Jan 3, 2025 Jan 7, 2025 Lebwohl David EVP, Chief Medical Officer Sell 42.5 -9,557 -9.83% ✗ $116.4K
Jan 3, 2025 Jan 7, 2025 Hicks Derek EVP, Chief Business Officer Sell 42.5 -6,502 -9.80% ✗ $79.2K
Jan 3, 2025 Jan 7, 2025 LEONARD JOHN M CEO Sell 40.0 -26,807 -2.61% ✗ $326.5K
Jan 3, 2025 Jan 7, 2025 Sepp-Lorenzino Laura EVP, Chief Scientific Officer Sell 42.5 -8,966 -10.38% ✗ $109.2K
Jan 2, 2025 Jan 6, 2025 Clark Eliana EVP, Chief Technical Officer Sell 42.5 -7,978 -11.08% ✗ $97.1K
Jan 1, 2025 Jan 3, 2025 Lebwohl David EVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 1, 2025 Jan 3, 2025 Sepp-Lorenzino Laura EVP, Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 1, 2025 Jan 3, 2025 LEONARD JOHN M CEO Neutral 52.5 - 0.00% ✗ -
Oct 2, 2024 Oct 4, 2024 Dube Michael P VP, Chief Accounting Officer Sell 46.3 -2,012 -4.10% ✗ $38.2K
Jul 22, 2024 Jul 24, 2024 Dulac Edward J III CFO Neutral 90.0 +66,324 100.00% ✗ -
Jul 24, 2024 Dulac Edward J III CFO Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 3, 2024 Clark Eliana EVP, Chief Technical Officer Sell 37.5 -405 -0.56% ✗ $9.3K
Jul 1, 2024 Jul 3, 2024 Dube Michael P VP, PAO and Interim PFO Neutral 90.0 +17,801 57.01% ✗ -
Jun 17, 2024 Jun 20, 2024 Verwiel Frank Director Sell 32.5 -1,505 -7.74% ✓ $37.6K
Jun 17, 2024 Goff Brian Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 17, 2024 Goff Brian Director Neutral 90.0 +15,409 100.00% ✗ -
Jun 12, 2024 Jun 14, 2024 Verwiel Frank Director Neutral 90.0 +7,737 66.04% ✗ -
Jun 12, 2024 Jun 14, 2024 Keresty Georgia Director Neutral 90.0 +7,737 47.92% ✗ -
Jun 12, 2024 Jun 14, 2024 GOODMAN JESSE Director Neutral 90.0 +7,737 66.04% ✗ -
Jun 12, 2024 Jun 14, 2024 Cohen Fred E Director Neutral 90.0 +7,737 18.55% ✗ -
Jun 12, 2024 Jun 14, 2024 Bhanji Muna Director Neutral 90.0 +7,737 64.50% ✗ -
Jun 12, 2024 Jun 14, 2024 CHASE WILLIAM J Director Neutral 90.0 +7,737 40.82% ✗ -
Apr 22, 2024 Dube Michael P Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Mar 1, 2024 Mar 5, 2024 Sepp-Lorenzino Laura EVP, Chief Scientific Officer Neutral 90.0 +37,966 86.43% ✗ -
Mar 1, 2024 Mar 5, 2024 BASTA JAMES EVP, General Counsel Sell 95.0 +30,097 58.47% ✗ $75.8K
Mar 1, 2024 Mar 5, 2024 Hicks Derek EVP, Chief Business Officer Neutral 90.0 +29,393 79.47% ✗ -
Mar 1, 2024 Mar 5, 2024 Clark Eliana EVP, Chief Technical Officer Sell 91.3 +30,625 74.98% ✗ $20K
Mar 1, 2024 Mar 5, 2024 LEONARD JOHN M CEO Neutral 90.0 +113,586 12.55% ✗ -
Mar 1, 2024 Mar 5, 2024 Lebwohl David EVP, Chief Medical Officer Neutral 90.0 +38,701 71.18% ✗ -
Mar 1, 2024 Mar 5, 2024 Goddard Glenn CFO Neutral 90.0 +28,628 70.54% ✗ -
Jan 8, 2024 Jan 10, 2024 Sepp-Lorenzino Laura EVP, Chief Scientific Officer Sell 37.5 -2,275 -4.92% ✓ $65.7K
Jan 3, 2024 Jan 5, 2024 LEONARD JOHN M CEO Sell 40.0 -19,223 -2.08% ✗ $566.3K
Jan 3, 2024 Jan 5, 2024 Lebwohl David EVP, Chief Medical Officer Sell 42.5 -5,843 -9.70% ✗ $172.1K
Jan 3, 2024 Jan 5, 2024 Sepp-Lorenzino Laura EVP, Chief Scientific Officer Sell 42.5 -5,532 -10.69% ✗ $163K
Jan 3, 2024 Jan 5, 2024 Goddard Glenn CFO Sell 42.5 -5,365 -11.68% ✗ $158.1K
Jan 3, 2024 Jan 5, 2024 Hicks Derek EVP, Chief Business Officer Sell 42.5 -3,877 -9.49% ✗ $114.2K
Jan 3, 2024 Jan 5, 2024 BASTA JAMES EVP, General Counsel Sell 42.5 -3,805 -6.88% ✗ $112.1K
Jan 3, 2024 Jan 5, 2024 Clark Eliana EVP, Chief Technical Officer Sell 42.5 -4,608 -10.14% ✗ $136K
Jan 1, 2024 Jan 3, 2024 Sepp-Lorenzino Laura EVP, Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 1, 2024 Jan 3, 2024 Lebwohl David EVP, Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 1, 2024 Jan 3, 2024 LEONARD JOHN M CEO Neutral 52.5 - 0.00% ✗ -
Jan 1, 2024 Jan 3, 2024 Goddard Glenn CFO Neutral 52.5 - 0.00% ✗ -
Oct 31, 2023 Nov 2, 2023 Bhanji Muna Director Sell 46.3 -265 -2.16% ✓ $6.3K
Jul 31, 2023 Aug 2, 2023 Bhanji Muna Director Sell 45.0 -265 -2.12% ✓ $11.2K
Jul 6, 2023 Jul 10, 2023 Bhanji Muna Director Sell 25.0 -1,867 -12.97% ✓ $73.4K
Jul 3, 2023 Jul 6, 2023 Clark Eliana EVP, Chief Technical Officer Sell 36.3 -360 -0.79% ✗ $14.6K
Jun 20, 2023 Jun 22, 2023 Clark Eliana EVP, Chief Technical Officer Sell 28.8 -5,000 -9.97% ✓ $225K
Jun 14, 2023 Jun 16, 2023 CHASE WILLIAM J Director Neutral 85.0 +1,673 9.68% ✗ -
Jun 14, 2023 Jun 16, 2023 Verwiel Frank Director Neutral 90.0 +4,425 60.69% ✗ -
Jun 14, 2023 Jun 16, 2023 Keresty Georgia Director Neutral 90.0 +4,425 37.75% ✗ -
Jun 14, 2023 Jun 16, 2023 GOODMAN JESSE Director Neutral 90.0 +4,425 60.69% ✗ -
Jun 14, 2023 Jun 16, 2023 Crowley John F Director Neutral 90.0 +4,425 60.69% ✗ -
Jun 14, 2023 Jun 16, 2023 Cohen Fred E Director Neutral 90.0 +4,425 11.87% ✗ -
Jun 14, 2023 Jun 16, 2023 Bhanji Muna Director Neutral 90.0 +4,425 44.39% ✗ -
Apr 14, 2023 Apr 18, 2023 CHASE WILLIAM J Director Neutral 90.0 +10,483 154.16% ✗ -
Apr 18, 2023 CHASE WILLIAM J Director Neutral 52.5 - 0.00% ✗ -
Mar 1, 2023 Mar 3, 2023 Hicks Derek EVP, Chief Business Officer Neutral 90.0 +23,558 136.13% ✗ -
Mar 1, 2023 Mar 3, 2023 Goddard Glenn CFO Neutral 90.0 +27,484 178.42% ✗ -